Your session is about to expire
← Back to Search
Tailored Adherence Program for Young Adults with Cancer
Study Summary
This trial will test a tailored program for 40 young adults with cancer to see if it meets criteria and is easy/acceptable to use.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not fluent in English.I am taking oral chemotherapy or medication to prevent illness.My doctor, caregiver, or I have decided I can't join due to my health or treatment.I choose not to use an electronic monitoring device.I have been diagnosed with cancer.I am between 15 and 24 years old.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Group 1: Tailored Program
- Group 2: Feedback Program
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are individuals who are below the age of 80 being admitted to this medical trial?
"Participants must be between 15 and 24 years old in order to qualify for this clinical trial."
What are the eligibility criteria for participation in this trial?
"This clinical trial is welcoming 40 individuals aged 15-24 who have been diagnosed with cancer and are currently taking oral chemotherapy or prophylactic medication. It is essential that applicants meet these criteria before applying for the study."
Are there any vacancies to join this scientific exploration?
"According to the clinicaltrials.gov database, this study is not presently accepting new participants. Initially posted on February 6th 2023 and last edited January 20th 2023, it appears that recruitment has ended for the time being. There are still 556 other trials actively seeking patients at present though."
Share this study with friends
Copy Link
Messenger